Accès gratuit
Numéro
Ann. Fr. Med. Urgence
Volume 8, Numéro 3, Juin 2018
Page(s) 172 - 177
Section Mise au point / Update
DOI https://doi.org/10.3166/afmu-2018-0043
Publié en ligne 20 mai 2018
  • Jehlé E, Honnart D, Grasleguen C, et al (2012) Traumatisme crânien léger (score de Glasgow de 13 à 15) : triage, évaluation, examens complémentaires et prise en charge précoce chez le nouveau-né, l’enfant et l’adulte. Ann Fr Med Urgence 2:199–214 [CrossRef] [Google Scholar]
  • Jehlé E, Ray P, Tazarourte K, et al (2014) Intérêt du dosage sérique de la protéine S100β dans la prise en charge du traumatisme crânien léger. Ann Fr Med Urgence 4:S1–S10 [CrossRef] [Google Scholar]
  • Kuberappa PH, Bagalad BS, Ananthaneni A, et al (2016) Certainty of S100β from physiology to pathology. J Clin Diagn Res 10:ZE10–5 [Google Scholar]
  • Pelinka LE, Kroepfl A, Leixnering M, et al (2004) GFAP versus S100β in serum after traumatic brain injury: relationship to brain damage and outcome. J Neurotrauma 21:1553–61 [CrossRef] [PubMed] [Google Scholar]
  • Harpio R, Einarsson R (2004) S100 proteins as cancer biomarkers with focus on S100β in malignant melanoma. Clin Biochem 37:512–8 [CrossRef] [PubMed] [Google Scholar]
  • Coulthart MB, Jansen GH, Olsen E, et al (2011) Diagnostic accuracy of cerebrospinal fluid protein markers for sporadic Creutzfeldt-Jakob disease in Canada: a 6-year prospective study. BMC Neurol 11:133 [CrossRef] [PubMed] [Google Scholar]
  • Stiell IG, Wells GA, Vandemheen K, et al (2001) The Canadian CT Head Rule for patients with minor head injury. Lancet 357:1391–6 [CrossRef] [PubMed] [Google Scholar]
  • Haydel MJ, Preston CA, Mills TJ, et al (2000) Indications for computed tomography in patients with minor head injury. N Engl J Med 343:100–5 [CrossRef] [PubMed] [Google Scholar]
  • Smits M, Dippel DW, de Haan GG, et al (2005) External validation of the Canadian CT Head Rule and the New Orleans Criteria for CT scanning in patients with minor head injury. JAMA 294:1519–25 [CrossRef] [PubMed] [Google Scholar]
  • Zongo D, Ribéreau-Gayon R, Masson F, et al (2012) S100β protein as a screening tool for the early assessment of minor head injury. Ann Emerg Med 59:209–18 [CrossRef] [PubMed] [Google Scholar]
  • Biberthaler P, Linsenmeier U, Pfeifer KJ, et al (2006) Serum S-100B concentration provides additional information for the indication of computed tomography in patients after minor head injury: a prospective multicenter study. Shock 25:446–53 [CrossRef] [Google Scholar]
  • Calcagnile O, Undén L, Undén J (2012) Clinical validation of S100β use in management of mild head injury. BMC Emerg Med 27:13 [CrossRef] [Google Scholar]
  • Undén J, Ingebrigtsen T, Romner B, Scandinavian Neurotrauma Committee (SNC) (2013) Scandinavian guidelines for initial management of minimal, mild and moderate head injuries in adults: an evidence and consensus-based update. BMC Med 11:50 [CrossRef] [PubMed] [Google Scholar]
  • Laribi S, Kansao J, Borderie D, et al (2014) S100β blood level measurement to exclude cerebral lesions after minor head injury: the multicenter STIC-S100 French study. Clin Chem Lab Med 52:527–36 [CrossRef] [PubMed] [Google Scholar]
  • Birlea SA (2017) S100β: correlation with active vitiligo depigmentation. J Invest Dermatol 137:1408–10 [CrossRef] [PubMed] [Google Scholar]
  • Bresnick AR, Weber DJ, Zimmer DB (2015) S100 proteins in cancer. Nat Rev Cancer 15:96–109 [CrossRef] [PubMed] [Google Scholar]
  • Li F, Men X, Zhang W (2014) S100 protein in breast tumor. Indian J Cancer 3:e67–e71 [Google Scholar]
  • Leclerc E, Vetter SW (2015) The role of S100 proteins and their receptor RAGE in pancreatic cancer. Biochim Biophys Acta 1852:2706–11 [CrossRef] [PubMed] [Google Scholar]
  • Moravkova P, Kohoutova D, Rejchrt S (2016) Role of S100 proteins in colorectal carcinogenesis. Gastroenterol Res Pract 2016:2632703 [CrossRef] [Google Scholar]
  • Tydén H, Lood C, Gullstrand B, et al (2017) Pro-inflammatory S100 proteins are associated with glomerulonephritis and anti-dsDNA antibodies in systemic lupus erythematosus. Lupus 26:139–49 [CrossRef] [PubMed] [Google Scholar]
  • Boschetti G, Garnero P, Moussata D, et al (2015) Accuracies of serum and fecal S100 proteins (calprotectin and calgranulin C) to predict the response to TNF antagonists in patients with Crohn’s disease. Inflamm Bowel Dis 21:331–6 [CrossRef] [PubMed] [Google Scholar]
  • Benedict C, Cedernaes J, Giedraitis V, et al (2014) Acute sleep deprivation increases serum levels of neuron-specific enolase (NSE) and S100 calcium binding protein B (S-100B) in healthy young men. Sleep 37:195–8 [CrossRef] [PubMed] [Google Scholar]
  • Roudsari B, Psoter KJ, Fine GC, Jarvik JG (2012) Falls, older adults, and the trend in utilization of CT in a level I trauma center. AJR Am J Roentgenol 198:985–91 [CrossRef] [PubMed] [Google Scholar]
  • United States Government Accountability Office (2008) Rapid spending growth and shift to physician offices indicate need for CMS to consider additional management practices. https://www.gao.gov/new.items/d08452.pdf (Dernier accès le 8 janvier 2018) [Google Scholar]
  • Brenner DJ, Hall EJ (2007) Computed tomography: an increasing source of radiation exposure. N Engl J Med 357:2277–84 [CrossRef] [PubMed] [Google Scholar]
  • Yuan MK, Tsai DC, Chang SC, et al (2013) The risk of cataract associated with repeated head and neck CT studies: a nationwide population-based study. AJR Am J Roentgenol 201:626–30 [CrossRef] [PubMed] [Google Scholar]
  • Richardson DB (2006) Increase in patient mortality at 10 days associated with emergency department overcrowding. Med J Aust 184:213–6 [PubMed] [Google Scholar]
  • Sprivulis PC, Da Silva JA, Jacobs IG, et al (2006) The association between hospital overcrowding and mortality among patients admitted via Western Australian emergency departments. Med J Aust 184:208–12 [PubMed] [Google Scholar]
  • Thaler HW, Schmidsfeld J, Pusch M, et al (2015) Evaluation of S100β in the diagnosis of suspected intracranial haemorrhage after minor head injury in patients who are receiving platelet aggregation inhibitors and in patients 65 years of age and older. J Neurosurg 123:1202–8 [CrossRef] [PubMed] [Google Scholar]
  • David A, Mari C, Vignaud F, et al (2017) Evaluation of S100β blood level as a biomarker to avoid computed tomography in patients with mild head trauma under antithrombotic medication. Diagn Interv Imaging 98:551–6 [CrossRef] [PubMed] [Google Scholar]
  • Green AJ, Harvey RJ, Thompson EJ, Rossor MN (1997) Increased S100β in the cerebrospinal fluid of patients with frontotemporal dementia. Neurosci Lett 235:5–8 [CrossRef] [PubMed] [Google Scholar]
  • Peskind ER, Griffin WS, Akama KT, et al (2001) Cerebrospinal fluid S100β is elevated in the earlier stages of Alzheimer’s disease. Neurochem Int 39:409–13 [CrossRef] [PubMed] [Google Scholar]
  • Petzold A, Jenkins R, Watt HC, et al (2003) Cerebrospinal fluid S100β correlates with brain atrophy in Alzheimer’s disease. Neurosci Lett 336:167–70 [CrossRef] [PubMed] [Google Scholar]
  • Woertgen C, Rothoerl RD, Wiesmann M, et al (2002) Glial and neuronal serum markers after controlled cortical impact injury in the rat. Acta Neurochir Suppl 81:205–7 [PubMed] [Google Scholar]
  • Egea-Guerrero JJ, Murillo-Cabezas F, Rodríguez-Rodríguez A, et al (2014) An experimental model of mass-type brain damage in the rat: expression of brain damage based on neurospecific enolase and protein S100β. Med Intensiva 38:218–25 [CrossRef] [Google Scholar]
  • Tolias CM, Bullock MR (2004) Critical appraisal of neuroprotection trials in head injury: what have we learned? NeuroRx 1:71–9 [CrossRef] [Google Scholar]
  • Egea-Guerrero JJ, Revuelto-Rey J, Murillo-Cabezas F, et al (2012) Accuracy of the S100β protein as a marker of brain damage in traumatic brain injury. Brain Inj 26:76–82 [CrossRef] [PubMed] [Google Scholar]
  • Korfias S, Stranjalis G, Boviatsis E, et al (2007) Serum S-100B protein monitoring in patients with severe traumatic brain injury. Intensive Care Med 33:255–60 [CrossRef] [PubMed] [Google Scholar]
  • Nylén K, Ost M, Csajbok LZ, et al (2008) Serum levels of S100β, S100A1β and S100β are all related to outcome after severe traumatic brain injury. Acta Neurochir (Wien) 150:221–7 [CrossRef] [PubMed] [Google Scholar]
  • Kellermann I, Kleindienst A, Hore N, et al (2016) Early CSF and serum S100β concentrations for outcome prediction in traumatic brain injury and subarachnoid hemorrhage. Clin Neurol Neurosurg 145:79–83 [CrossRef] [PubMed] [Google Scholar]
  • Herrmann M, Jost S, Kutz S, et al (2000) Temporal profile of release of neurobiochemical markers of brain damage after traumatic brain injury is associated with intracranial pathology as demonstrated in cranial computerized tomography. J Neurotrauma 17:113–22 [CrossRef] [PubMed] [Google Scholar]
  • Gonzćlez-Mao MC, Repáraz-Andrade A, Del Campo-Pérez V, et al (2011) Model predicting survival/exitus after traumatic brain injury: biomarker S100β 24 h. Clin Lab 57:587–97 [PubMed] [Google Scholar]
  • Knapik P, Knapik M, Partyka R, et al (2016) Utility of serum concentration of protein S100 at admission to the medical intensive care unit in prediction of permanent neurological injury. Kardiochir Torakochirurgia Pol 13:347–52 [PubMed] [Google Scholar]
  • Da Rocha AB, Schneider RF, de Freitas GR, et al (2006) Role of serum S100β as a predictive marker of fatal outcome following isolated severe head injury or multitrauma in males. Clin Chem Lab Med 44:1234–42 [CrossRef] [PubMed] [Google Scholar]
  • Egea-Guerrero JJ, Murillo-Cabezas F, Gordillo-Escobar E, et al (2013) S100β protein may detect brain death development after severe traumatic brain injury. J Neurotrauma 30:1762–9 [CrossRef] [PubMed] [Google Scholar]
  • Calcagnile O, Anell A, Undén J (2016) The addition of S100β to guidelines for management of mild head injury is potentially cost saving. BMC Neurol 16:200 [CrossRef] [PubMed] [Google Scholar]
  • Kuppermann N, Holmes JF, Dayan PS, et al (2009) Identification of children at very low risk of clinically-important brain injuries after head trauma: a prospective cohort study. Lancet 374:1160–70 [CrossRef] [PubMed] [Google Scholar]
  • Pearce MS, Salotti JA, Little MP, et al (2012) Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumors: a retrospective cohort study. Lancet 380:499–505 [CrossRef] [PubMed] [Google Scholar]
  • Mathews JD, Forsythe AV, Brady Z, et al (2013) Cancer risk in 680,000 people exposed to computed tomography scans in childhood or adolescence: data linkage study of 11 million Australians. BMJ 346:f2360 [CrossRef] [PubMed] [Google Scholar]
  • Miglioretti DL, Johnson E, Williams A, et al (2013) The use of computed tomography in pediatrics and the associated radiation exposure and estimated cancer risk. JAMA Pediatr 167:700–7 [CrossRef] [PubMed] [Google Scholar]
  • Bouvier D, Fournier M, Dauphin JB, et al (2012) Serum S100β determination in the management of pediatric mild traumatic brain injury. Clin Chem 58:1116–22 [CrossRef] [PubMed] [Google Scholar]
  • Castellani C, Bimbashi P, Ruttenstock E, et al (2009) Neuroprotein S100β: a useful parameter in paediatric patients with mild traumatic brain injury? Acta Paediatr 98:1607–12 [CrossRef] [PubMed] [Google Scholar]
  • Babcock L, Byczkowski T, Mookerjee S, et al (2012) Ability of S-100B to predict severity and cranial CT results in children with TBI. Brain Inj 26:1372–80 [CrossRef] [PubMed] [Google Scholar]
  • Bechtel K, Frasure S, Marshall C, et al (2009) Relationship of serum S100β levels and intracranial injury in children with closed head trauma. Pediatrics 124:e697–e704 [CrossRef] [PubMed] [Google Scholar]
  • Au AK, Bell MJ, Fink EL, et al (2018) Brain-specific serum biomarkers predict neurological morbidity in diagnostically diverse pediatric intensive care unit patients. Neurocrit Care 28:26–34. doi: 10.1007/s12028-017-0414-7 [CrossRef] [PubMed] [Google Scholar]
  • Kramer P, Miera O, Berger F, et al (2018) Prognostic value of serum biomarkers of cerebral injury in classifying neurological outcome after paediatric resuscitation. Resuscitation 122:113–20 [CrossRef] [PubMed] [Google Scholar]
  • Peng QL, Tao SH, Yu N, et al (2017) Elevated levels of cerebrospinal fluid S100β are associated with brain injury and unfavorable outcomes in children with central nervous system infections. Int J Neurosci J127:1 [CrossRef] [Google Scholar]
  • Manzano S, Holzinger IB, Kellenberger CJ, et al (2016) Diagnostic performance of S100β protein serum measurement in detecting intracranial injury in children with mild head trauma. Emerg Med J 33:42–6 [CrossRef] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.